Status:
TERMINATED
ESP Block for Laparoscopic Nephrectomy Surgeries
Lead Sponsor:
McMaster University
Collaborating Sponsors:
St. Joseph's Healthcare Hamilton
Conditions:
Kidney Cancer
Post-surgical Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Nephrectomy (kidney removal) is one of the most common surgical procedures in urologic practice. Recent advances in laparoscopic (keyhole) procedures have resulted in a significant decrease in open ne...
Detailed Description
While post-operative pain seems to be slightly decreased compared to open nephrectomies, pain from laparoscopic nephrectomy is still significant and opioid consumption is similar.Adequate management o...
Eligibility Criteria
Inclusion
- Patients requiring laparoscopic nephrectomy and partial nephrectomy for malignancy
- Patients of age 18 and over
- BMI \< 40
- Patients who are expected to stay in-hospital overnight after surgery
Exclusion
- Patient refusal
- Contraindications to paravertebral blocks: Infection at the site of needle insertion, empyema, allergy to local anesthetic drugs, and tumor occupying the thoracic paravertebral space, coagulopathy, bleeding disorder or therapeutic anticoagulation
- Known allergy to local anesthetics
- Inability to provide informed consent
- Inability to use a PCA due to languate or comprehension barriers
- BMI \>= 40
- Any patient on opioids for greater than or equal to 3 months duration prior to surgery
- Patients with chronic pain syndromes
- Donor nephrectomies due to incision location
- Cystic kidney because of very large incisions
Key Trial Info
Start Date :
January 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 16 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04085237
Start Date
January 4 2020
End Date
October 16 2023
Last Update
February 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada, L8N 4A6